Furthermore, in the subcutaneous tumour xenograft model, the expression of USP14 and FASN were increased, while the protein levels of GPX4 were decreased in the group with GSTM3 overexpression (Supplementary Fig. 8A). The gene discussed is GPX4; the disease is neoplasm.